Published on
Pathology - Osteoporosis:
.
I. Definition & Epidemiology:
  • Definition: Osteoporosis is a metabolic bone disease characterized by decreased bone mass, increased bone fragility, and a heightened risk of fractures. It's a silent disease often undetected until a fracture occurs.
  • Epidemiology: Extremely common, predominantly affecting elderly women, although it can occur in all ages.
II. Etiology (Causes):
  • Primary Cause: Estrogen deficiency (particularly post-menopause in women) is a major risk factor.
  • Other Contributing Factors:
    • Glucocorticoid therapy (steroids)
    • Cushing's syndrome
    • Hyperparathyroidism
    • Hyperthyroidism
    • Celiac disease
    • Inflammatory bowel disease
III. Pathogenesis (Disease Mechanisms):
  • Bone Mass Determination: Bone mass in later life is influenced by:
    • Peak bone mass: Achieved during early adulthood (largely genetic, but modifiable by nutrition, physical activity, and early life health).
    • Rate of bone loss: Increases with age due to:
      • Decreased bone turnover
      • Reduced physical activity
      • Diminished calcium absorption (gut)
      • Accelerated bone loss in women post-menopause (due to estrogen deficiency).
  • Glucocorticoid Effect: Glucocorticoids negatively impact bone health by:
    • Decreasing osteoblast activity and lifespan
    • Reducing gut calcium absorption
    • Increasing renal calcium loss
    • Suppressing sex hormone production (further increasing bone loss).
IV. Presentation (Clinical Features):
  • Often Asymptomatic: Most cases remain undiagnosed until a fracture occurs.
  • Fracture Sites: Common fracture locations include:
    • Vertebrae (leading to height loss and kyphosis – curvature of the spine) – can occur spontaneously or with minimal trauma.
    • Distal radius (Colles' fracture) – typically from a fall.
    • Neck of femur (hip fracture) – often from a fall from standing height or less.
V. Histopathology (Microscopic Appearance):
  • Cancellous Bone (spongy bone): Thinning and disconnection of trabeculae (supporting bone structures).
  • Cortical Bone (compact bone): Thinning with enlargement of Haversian canals (channels containing blood vessels).
VI. Prognosis:
  • Hip Fractures (Neck of Femur): Pose the most significant risk, often requiring hospitalization and surgery. Mortality risk is increased in elderly patients with other health problems.
**


Picture
Published on
Pathology - Rheumatoid Arthritis
I. Definition & Epidemiology
  • Definition: RA is a systemic autoimmune disease primarily affecting synovial joints. It's characterized by chronic inflammation.
  • Epidemiology: Affects approximately 1% of the population, with a significantly higher prevalence in young to middle-aged women.
II. Etiology & Pathogenesis
  • Etiology (Cause): The initial trigger for RA remains unknown. However, once inflammation starts, it becomes self-sustaining.
  • Pathogenesis (Mechanism):
    • Inflammation: The synovium (joint lining) is infiltrated by CD4+ T-cells, B-cells, plasma cells, and macrophages, leading to inflammation.
    • Pannus Formation: The inflamed synovium proliferates, forming pannus – a hyperplastic mass of synovial tissue.
    • Joint Destruction: Pannus erodes articular cartilage, resulting in joint damage.
III. Clinical Presentation
  • Joint Involvement: Symmetrical swelling, pain, and stiffness, predominantly affecting small joints of the hands and feet. Morning stiffness is a characteristic symptom.
IV. Serology & Diagnosis
  • Rheumatoid Factor (RF): An autoantibody targeting the Fc portion of IgG. Positive in ~70% of RA patients, but also found in other autoimmune diseases and some healthy individuals, limiting its specificity.
  • Anti-citrullinated protein antibodies (ACPAs): Newer, more specific antibodies for diagnosing RA, but not as widely available as RF.
V. Extra-articular Manifestations (Beyond the Joints)
RA can affect multiple organ systems:
  • Cardiovascular: Ischemic heart disease, pericarditis
  • Vascular: Accelerated atherosclerosis, vasculitis
  • Hematological: Anemia, splenomegaly
  • Pulmonary: Pulmonary fibrosis, pleuritis
  • Skin: Rheumatoid nodules, erythema nodosum, pyoderma gangrenosum
  • Neurological: Peripheral neuropathy, stroke
  • Amyloidosis: Deposition of serum amyloid A, leading to AA amyloidosis in various organs.
VI. Histopathology (Microscopic Examination)
  • Synovial Hyperplasia: Marked increase in synovial tissue.
  • Inflammatory Infiltrate: A significant presence of lymphocytes and plasma cells.
  • Germinal Centers: Formation of germinal centers within lymphoid aggregates is a typical finding.
VII. Prognosis
RA has a variable course:
  • Remission: Approximately 25% experience long-term remission.
  • Mild-to-Moderate Disability: About 50% have chronic disease with mild-to-moderate disability.
  • Severe Disability: Approximately 25% experience progressive disease leading to severe disability.
Key Concepts for Review:
  • Autoimmune nature: RA is driven by the body's immune system attacking its own tissues.
  • Synovitis: Inflammation of the synovial membrane is central to the disease process.
  • Pannus formation & joint destruction: Understand the sequence of events leading to joint damage.
  • Diagnostic markers: Compare the sensitivity and specificity of RF and ACPAs.
  • Systemic involvement: Be aware of the diverse extra-articular manifestations.
Picture
Published on
Pathology - Osteoarthritis
I. Definition & Epidemiology:
  • Definition: Osteoarthritis (OA) is a group of diseases causing joint degradation. Crucially, it's not a single disease but a collection of similar conditions.
  • Epidemiology: OA is the most common joint disease. In the UK, approximately 2 million people experience symptomatic OA. It primarily affects the elderly population.
II. Aetiology (Causes):
  • Primary OA: In most cases, the cause of OA is unknown (primary OA). This highlights the complexity of the disease and the challenges in pinpointing a single cause.
  • Secondary OA: OA can also develop as a consequence of other joint disorders (secondary OA). Examples include rheumatoid arthritis and gout, where pre-existing joint damage sets the stage for OA development. Understanding this distinction is vital – treatment differs depending on the underlying cause.
III. Pathogenesis (Mechanism of Disease):
  • Cartilage Damage: The primary pathological change is damage to the articular cartilage, the smooth tissue covering joint surfaces. This damage is central to understanding OA's progression.
  • Inflammation & Metalloproteinases: Low-grade inflammation within the joint plays a crucial role. This inflammation causes chondrocytes (cartilage cells) to release metalloproteinases, enzymes that break down the cartilage matrix, leading to further cartilage loss.
  • Subchondral Bone Response: As cartilage is lost, the underlying bone becomes exposed. The bone responds by thickening (sclerosis) – a compensatory but ultimately unhelpful response. This bone thickening contributes to the pain and stiffness experienced by patients.
IV. Presentation (Symptoms):
  • Pain, Tenderness, Stiffness: The classic symptoms are pain, tenderness, and stiffness in the affected joint(s). It's important to note that symptom severity varies greatly between individuals.
  • Activity-Related Worsening: Symptoms typically worsen throughout the day, particularly with increased activity. This contrasts with some other inflammatory arthritides where stiffness is worse in the morning.
  • Commonly Affected Joints: OA most commonly affects the hip, knee, spine, and small joints of the hands, but it can affect any joint. Knowing the typical locations helps in differential diagnosis.
V. Histopathology (Microscopic Findings):
  • Cartilage Loss & Thinning: Microscopic examination reveals thinned and lost articular cartilage. This confirms the central role of cartilage degeneration in the disease process.
  • Subchondral Bone Sclerosis: Thickening and sclerosis (increased density) of the subchondral bone are also observed. This supports the clinical observation of bone changes in OA.
VI. Prognosis (Outcome):
  • Progressive Worsening: OA generally worsens over time. This emphasizes the need for early diagnosis and management to slow progression.
  • Analgesics & Joint Replacement: Management typically involves analgesics (pain relievers) to manage symptoms. In severe cases, joint replacement surgery may be necessary. This highlights the potential long-term impact of the disease.​
Picture
Published on
Pathology - Malignant Bone Tumors
I. Metastatic Bone Tumors
  • Prevalence: The vast majority of malignant bone tumors are metastatic (secondary), meaning they spread from another primary cancer site.
  • Primary Sources: Common primary sites include lung, breast, kidney, thyroid, and prostate carcinomas.
  • Bone Destruction: Most metastatic bone tumors are osteolytic, meaning they break down bone tissue. An exception is prostate cancer metastases, which are typically osteosclerotic (stimulate new bone formation).
  • Hypercalcemia: Bone metastases are a frequent cause of hypercalcemia (high blood calcium levels).
II. Primary Bone Tumors
A. Osteosarcoma
  • Definition: A malignant bone-forming tumor; the most common primary malignant bone tumor.
  • Demographics: Most commonly affects individuals aged 5-25, presenting with persistent deep pain in a long bone, often accompanied by a palpable mass. Elderly cases are often secondary to Paget's disease.
  • Histology: Composed of atypical cells that produce osteoid (unmineralized bone matrix).
  • Spread: Highly malignant with early and rapid hematogenous (bloodstream) spread, primarily to the lungs.
  • Prognosis: Strongly dependent on response to preoperative therapy. Responders have excellent survival (80-90%), while non-responders have poor survival (<15%).< />pan>
B. Chondrosarcoma
  • Definition: A malignant cartilage-forming tumor; the second most common primary malignant bone tumor.
  • Demographics: Primarily affects adults over 50 years old.
  • Location: Most common in pelvic bones.
  • Histology: Composed of variably atypical cells producing a cartilaginous matrix. Graded 1-3, with most being grades 1 or 2.
  • Prognosis: Histological grade is the key prognostic factor. Grade 1 tumors have a 90% 5-year survival rate, while grades 2 and 3 have closer to 50%.
C. Ewing's Sarcoma
  • Definition: A malignant round cell tumor of bone.
  • Demographics: Most common in children and adolescents under 20 years old.
  • Presentation: Presents with pain and a mass in long bones, pelvis, or ribs.
  • Histology: Small round tumor cells with scant cytoplasm; may form rosette-like structures; necrosis is common.
  • Genetics: Often shows a characteristic t(11;22) chromosomal translocation fusing the EWS and FLI1 genes.
  • Prognosis: Survival rates are less than 50%, depending on stage, location, and tumor size.



Picture
Published on
Pathology - Osteomyelitis
I. Definition:
  • Infection of a bone. This is the core concept – remember this first and foremost.
II. Epidemiology (Who gets it?):
  • Can occur at any age, but patterns exist:
    • Acute hematogenous osteomyelitis: Primarily affects children (infection spreads through the bloodstream). This is a key age-related distinction.
    • Adults can develop osteomyelitis through other routes (see Acquisition).
III. Acquisition of Infection (How it happens):
This section outlines the pathways of infection, crucial for understanding the diverse presentations of the disease.
  • Hematogenous spread: Bloodstream infection reaching the bone (common in acute childhood cases). Understand this is the primary route in children.
  • Penetrating trauma: Open fractures or wounds allowing direct bacterial entry into the bone. This highlights a mechanism of injury.
  • Iatrogenic: Infection caused by medical procedures (e.g., joint replacement surgery, root canal). Remember that medical intervention itself can introduce infection.
  • Direct spread: Infection from a neighboring site (e.g., diabetic foot ulcer). This shows that osteomyelitis can be a secondary complication.
IV. Microbiology (What causes it?):
  • Staphylococcus aureus (S. aureus): The most common causative agent. This is the most important microbe to remember.
  • Salmonella species: Predominant in patients with sickle cell disease. This is a specific risk factor to note. The underlying condition increases susceptibility.
V. Pathogenesis (What happens in the body?):
  • Inflammation: Infection triggers acute inflammation within the bone, leading to pus formation (suppurative inflammation). Inflammation is the body's response, but in this case it leads to bone damage.
  • Sequestrum formation: Necrotic (dead) bone fragments are formed. Understand “sequestrum” as a key term representing dead bone.
  • Chronic osteomyelitis: If the infection isn't eradicated, chronic inflammation leads to the formation of new bone around infected areas. This highlights the potential for a protracted, serious condition.
VI. Presentation (Symptoms):
  • Fever: A systemic indication of infection.
  • Bone pain: Localized to the affected bone.
  • Inability to weight-bear: Specifically relevant in children, impacting their mobility.
VII. Prognosis (Outcome and Treatment):
  • Aggressive treatment is essential: This requires intravenous antibiotics to kill bacteria and surgical debridement (removal of necrotic bone) to clear the infection. The treatment strategy needs to be aggressive.
  • Joint replacement complications: Osteomyelitis following joint replacement can result in prosthesis failure. This highlights a significant complication.
Key Concepts for Review:
  • Hematogenous spread is the most common route in children.
  • Staphylococcus aureus is the most frequent causative agent.
  • Sequestrum refers to dead bone fragments.
  • Treatment requires intravenous antibiotics and surgical debridement.
Picture
Published on
Pathology – Benign Bone Tumors
I. Osteochondroma
  • Definition: Benign bone-forming tumour.
  • Location: Solitary exophytic nodule arising from the metaphysis of long bones near the epiphyseal growth plate.
  • Population: Common in children.
  • Histology:
    • Outer fibrous perichondrium.
    • Cartilage cap.
    • Underlying bony stalk.
  • Key takeaway: Think "bone spur" growing outwards from the growth plate of a long bone in a child.
II. Chondroma
  • Definition: Benign cartilage-forming tumour.
  • Location: Two main types:
    • Enchondromas: Medulla of bones (hands and feet are common).
    • Periosteal chondromas: Surface of bone (proximal humerus is characteristic).
  • Presentation: Often discovered incidentally (no symptoms).
  • Histology: Chondrocytes within an abundant cartilaginous matrix.
  • Key takeaway: Cartilage-based tumour, location distinguishes the subtypes.
III. Osteoid Osteoma
  • Definition: Benign bone-forming tumour.
  • Location: Long bones of children/young adults (proximal femur is common).
  • Presentation: Characteristic nocturnal pain.
  • Radiographic Appearance: Small lucent nidus (<1cm) on plain radiographs.< />pan>
  • Histology: Well-circumscribed, hypervascular area of bony trabeculae surrounded by reactive bone.
  • Key takeaway: Small, painful lesion easily visualized on X-ray; pain is a key clinical feature.
IV. Giant Cell Tumour of Bone (GCTB)
  • Definition: Benign, but locally aggressive neoplasm.
  • Location: Ends of long bones.
  • Population: Young adults (20-45 years).
  • Presentation: Pain and swelling at the tumour site.
  • Histology: Sheets of neoplastic ovoid mononuclear cells with interspersed large osteoclast-like giant cells.
  • Prognosis: ~25% local recurrence rate after excision. Distant metastasis is rare.
  • Key takeaway: Although benign, its local aggressiveness and potential for recurrence are significant.
Picture
Published on
Pathology - Osteomalacia.
I. Definition & Epidemiology:
  • Definition: Osteomalacia is a metabolic bone disease. Crucially, it's characterized by inadequate mineralization of osteoid, resulting in soft, weakened bones. This means the bone matrix (osteoid) doesn't harden properly.
  • Epidemiology: Relatively rare in developed nations. Predominantly affects the elderly population.
II. Etiology (Causes):
  • Primary Cause: Almost all cases stem from vitamin D deficiency. Understanding the why behind the deficiency is critical.
  • Causes of Vitamin D Deficiency:
    • Insufficient sun exposure: Lack of UV-B radiation needed for vitamin D synthesis in the skin.
    • Malabsorption: Conditions affecting nutrient absorption from the gut (e.g., celiac disease, Crohn's disease).
    • Chronic liver disease: Impaired vitamin D metabolism.
    • Chronic kidney disease: Reduced ability to activate vitamin D in the kidneys.
III. Pathogenesis (Mechanism):
  • Bone Matrix Mineralization Failure: Insufficient mineralization of the bone matrix (osteoid) leads to a buildup of unmineralized osteoid. This is the hallmark of the disease.
  • Structural Weakness: The excess unmineralized osteoid weakens bone structure, resulting in increased risk of deformity and fractures. Think of it like unbaked cookie dough versus a properly baked cookie – the dough lacks structural integrity.
IV. Clinical Presentation (Symptoms):
  • Diffuse Bone Pain and Tenderness: This is a common presenting complaint, but it's important to remember that it's non-specific. Many other conditions cause bone pain.
  • Proximal Muscle Weakness: Weakness in the muscles of the shoulders and hips is another key symptom.
  • Undiagnosed Cases: A significant number of cases likely go undetected due to the nonspecific nature of symptoms, emphasizing the need for thorough investigation when appropriate.
V. Histopathology (Microscopic Findings):
  • Excessive Unmineralized Osteoid: Microscopic examination reveals bony trabeculae (bone struts) covered by a significantly thicker-than-normal layer of unmineralized osteoid. This is the definitive histopathological finding confirming the diagnosis.
VI. Prognosis & Treatment:
  • Treatment & Prognosis: Vitamin D supplementation typically leads to rapid bone mineralization and symptom resolution. However, some bone deformities may persist.
Key Concepts to Remember:
  • Osteoid: The unmineralized organic matrix of bone. It's the "building material" that should harden with calcium and phosphate.
  • Non-specific Symptoms: Osteomalacia's symptoms are not unique to the disease, making diagnosis challenging.
  • Vitamin D's Crucial Role: Vitamin D is essential for calcium absorption and bone mineralization.
Picture
Published on

Pathology - Epilepsy

I. Definition & Epidemiology:

  • Epilepsy: A neurological disorder characterized by recurrent, unprovoked seizures resulting from abnormal brain electrical activity.
  • Prevalence: Affects approximately 1% of the population.

II. Etiology (Causes):

  • Idiopathic: In many cases, no identifiable cause is found.
  • Secondary Causes: Epilepsy can be associated with:
    • Structural lesions: Trauma, tumors (neoplasms), brain malformations.
    • Metabolic disorders: Alcohol abuse, electrolyte imbalances.
    • Infections: Various infections affecting the brain.

III. Seizure Types:

Seizures are categorized based on their clinical presentation and the involvement of brain hemispheres:

A. Partial Seizures (Focal Seizures): Originate in a specific area of one brain hemisphere.

  • Simple Partial Seizures: Consciousness remains intact. Examples include focal motor seizures (localized muscle twitching or jerking).
  • Complex Partial Seizures: Consciousness is impaired. Examples include staring spells, automatisms (repetitive, seemingly purposeless movements), and altered awareness.

B. Generalized Seizures: Involve both hemispheres simultaneously; consciousness is always impaired.

  • Absence Seizures ("Petit Mal"): Brief (<10 seconds) periods of unresponsiveness, often appearing as a momentary pause in activity (e.g., stopping mid-sentence). Common in childhood absence epilepsy.
  • Tonic-Clonic Seizures ("Grand Mal"): Characterized by a sudden loss of consciousness followed by stiffening (tonic phase) and rhythmic jerking (clonic phase) of the limbs.
  • Myoclonic Jerks: Sudden, brief, involuntary muscle contractions, often affecting the limbs. Common in juvenile myoclonic epilepsy.

IV. Specific Epilepsy Syndromes:

These are characterized by specific seizure types and age of onset:

  • Temporal Lobe Epilepsy:
    • Onset: Late childhood/adolescence.
    • Seizure Types: Primarily complex partial seizures (e.g., epigastric aura – strange feeling in the gut; déjà vu; olfactory hallucinations – strange smells), often progressing to secondary generalized tonic-clonic seizures.
    • Cause: Typically an epileptogenic focus (abnormal brain activity) in the temporal lobe.
  • Childhood Absence Epilepsy:
    • Onset: Ages 4-12.
    • Seizure Types: Primarily absence seizures. Some children may also experience tonic-clonic seizures.
    • Etiology: Idiopathic (no clear cause).
  • Juvenile Myoclonic Epilepsy:
    • Onset: Ages 8-20.
    • Seizure Types: Myoclonic jerks are most common, but absence and tonic-clonic seizures can also occur.
    • Etiology: Idiopathic (no clear cause).

V. Key Differences Summarized:

Feature

Partial Seizures

Generalized Seizures

Consciousness

May be intact (simple) or impaired (complex)

Always impaired

Brain Involvement

One hemisphere

Both hemispheres

Examples

Focal motor, complex partial

Absence, tonic-clonic, myoclonic
Published on

Pathology-Soft Tissue Tumours

I. Benign Tumours:

Tumour Type

Presentation

Histology

Key Features

Lipoma

Painless subcutaneous mass (limbs, trunk), adults.

Lobules of mature adipocytes.

Most common soft tissue tumour.

Angiolipoma

Painful, often multiple subcutaneous masses, adults. Upper limb (forearm) common.

Mature adipocytes & capillary-like vessels with fibrin microthrombi.

Pain is a key differentiator.

Spindle Cell Lipoma

Painless subcutaneous mass (upper back, shoulders, neck), adults. Male predilection.

Mature adipocytes, spindle cells, fibromyxoid stroma with thick collagen.

Location and patient demographics are important.

Angioleiomyoma

Painful subcutaneous mass, lower limbs. More common in women.

Mature smooth muscle cells around thick-walled blood vessels.

Pain and location are key.

Giant Cell Tumour of Tendon Sheath

Painless, slow-growing nodule (finger, toe). Peak age 20-40, female preponderance.

Round mononuclear cells, osteoclast-like multinucleated cells, macrophages, haemosiderin.

Location and cell types are characteristic.

Fibroma of Tendon Sheath

Firm nodule attached to tendon (finger). Young/middle-aged adults, male preponderance.

Bland fibroblasts, thin slit-like vessels in fibrous stroma.

Location and cellular composition are diagnostic.

II. Fibromatoses (Locally Aggressive, Non-Metastasizing):

  • Superficial: Dupuytren's contracture (palms), Ledderhose's disease (soles).
  • Deep (Desmoid fibromatosis): Limb girdles, abdominal wall, mesentery.
  • Histology: Bland spindled fibroblasts in broad fascicles, infiltrating surrounding structures. Significant local recurrence risk near vital structures.

III. Solitary Fibrous Tumour:

  • Slowly enlarging deep soft tissue mass in adults.
  • Histology: Haphazardly arranged bland fibroblastic cells, varying cellularity and collagenization, dilated branching blood vessels.
  • Mostly benign, but a small percentage can exhibit malignant behaviour.

IV. Malignant Tumours (Sarcomas):

Tumour Type

Presentation

Histology

Key Features

Liposarcoma

Most common soft tissue sarcoma. Adult, deep-seated mass (extremity, limb girdle, retroperitoneum).

Well-differentiated: Mature adipocytes with variation in cell size, bizarre hyperchromatic stromal cells. Common local recurrence, no metastasis.
Myxoid: Spindle cells, lipoblasts in myxoid stroma, t(12;16) translocation.
Pleomorphic: Pleomorphic cells, multivacuolated lipoblasts.

Deep location and histologic subtype are crucial.

Leiomyosarcoma

Enlarging mass (retroperitoneum or limbs), adults.

Fascicles of atypical smooth muscle cells.

50% metastasize.

Rhabdomyosarcoma

Embryonal: Young children (head/neck, genitourinary).
Alveolar: Older children/adolescents (limbs).
Pleomorphic: Adults (limbs), aggressive.

Skeletal muscle differentiation.

Age and location strongly indicate subtype.

Synovial Sarcoma

Young adults, longstanding pain, deep soft tissue mass.

Highly cellular spindle cells, epithelioid cells. t(X;18) translocation.

Aggressive, poor long-term survival.

Pleomorphic Undifferentiated Sarcoma

High-grade, large, deep-seated, aggressive. No specific differentiation identified.

No specific differentiation.

Aggressive behavior and lack of identifiable differentiation are defining features.
Published on
Pathology - -Septic Arthritis
I. Definition:
  • Infection within a joint. This is the core concept – remember this first.
II. Epidemiology (Who gets it?):
  • Any age: Septic arthritis can affect anyone.
  • Increased Risk: Individuals with pre-existing joint conditions are significantly more vulnerable. Think of this as a weakened defense system making the joint more susceptible.
III. Acquisition of Infection (How it happens):
  • Hematogenous Spread (Most Common): The infection travels through the bloodstream to the joint. This is the primary pathway.
  • Penetrating Trauma (Less Common): Infection can be introduced directly into the joint via injury (e.g., a puncture wound).
IV. Microbiology (What causes it?):
  • Staphylococcus aureus (S. aureus): This bacterium is the primary culprit in almost all cases. Memorize this.
V. Pathogenesis (How it develops):
  • Phagocyte Limitation: The joint space has limited access for phagocytes (immune cells that engulf and destroy pathogens). This makes it difficult for the body to fight the infection naturally. This is a key factor in why the infection spreads so rapidly.
  • Rapid Destruction: Septic arthritis progresses swiftly, causing irreversible joint damage if antibiotics aren't administered promptly. Early intervention is critical.
VI. Clinical Presentation (What it looks like):
  • Classic Signs of Inflammation: The affected joint is intensely painful, hot, red, and swollen. This is a hallmark of septic arthritis; remember these four key characteristics (pain, heat, redness, swelling).
VII. Diagnostic Tests:
  • Microscopy: Joint fluid analysis reveals neutrophils (a type of white blood cell indicating infection) but no crystals (ruling out gout or pseudogout).
  • Culture: Essential for identifying the specific bacteria (usually S. aureus) and determining its antibiotic susceptibility. Culturing both joint fluid and blood is crucial for accurate diagnosis and treatment.
VIII. Prognosis (What happens if untreated?):
  • Irreversible Joint Damage: Without appropriate antibiotic treatment, permanent joint destruction is inevitable. This highlights the urgency of prompt diagnosis and treatment.
Key Concepts to Master:
  • S. aureus is the most common cause.
  • Early antibiotic treatment is crucial to prevent irreversible joint damage.
  • The four cardinal signs of inflammation (pain, heat, redness, swelling) are present.
  • Joint fluid analysis is essential for diagnosis and guiding treatment.
Picture

Kembara Xtra 

Facts about medicine and its subtopic such as anatomy, physiology, biochemistry, pharmacology, medicine, pediatrics, psychiatry, obstetrics and gynecology and surgery.